MDB Capital Holdings, LLC Class A common logo

MDB Capital Holdings, LLC Class A common(MDBH)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$1.5
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for MDBH

11/13/2026: MDBH (1-star) is currently NOT-A-BUY. Pass it for now.

MDB Capital Holdings is a micro-cap investment holding company that combines a boutique broker-dealer with proprietary patent intelligence and early-stage technology incubation. The company's primary strength lies in its specialized ability to evaluate disruptive intellectual property through its PatentVest platform. Its core investment story revolves around capturing upside from early-stage tech innovators and expanding data subscription revenues. However, it faces notable risks, including persistent net losses, low trading liquidity, and vulnerability to cyclical micro-cap IPO activity. This stock suits risk-tolerant investors seeking alternative exposure to small-cap venture finance, with a close eye on deal flow recovery and cash burn metrics.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitOffers exposure to early-stage technology incubation, but micro-cap execution risks and operating losses temper immediate growth confidence.
Momentum investorStrong fit while signal remains positiveLow float and micro-cap status can trigger sharp short-term price movements when positive deal catalysts emerge.
Value investorWeak fitPersistent net losses and negative earnings make standard valuation metrics difficult to justify for traditional value strategies.
Dividend investorWeak fitThe company pays no dividends and reinvests capital into early-stage ventures.
Low-risk investorWeak fitHigh share price volatility, micro-cap liquidity constraints, and ongoing net losses present substantial risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighLow trading volume and small market capitalization can cause sharp daily percentage swings in share price.
Valuation riskHighNegative earnings and unpredictable micro-cap market valuations make fundamental pricing challenging.
Competition risk (boutique investment banking and IP analytics)Medium / highThe firm competes with established boutique underwriters and alternative data providers for deal flow.
Business qualityMediumNiche expertise in patent due diligence provides a unique moat, but overall profitability remains under pressure.
Dividend incomeLow / noneNo dividend distributions are paid to equity holders.
Execution riskHighSuccess depends heavily on successfully underwriting micro-cap companies and advancing early-stage R&D platforms.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 15.70M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 4.8K shares
Beta 1.4
52 Weeks Range 0.89 - 4.16
Updated Date 11/15/2026
52 Weeks Range 0.89 - 4.16
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) -2.18

Sector & Industry Intelligence

Sector

Financial Services

Constructive
Sentiment
Bullish
Momentum
BUY Breadth Improving
BUY participation
50.4%
Active BUY / eligible
61 / 121
30-Day BUY Count Change
+45
Market state
Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Capital Markets

BUY participation
0.0%
Active BUY / eligible
0 / 11
30-Day BUY Count Change
-1

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -47.58%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
MDBH receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
MDBH has moderate overall fundamentals (3 stars), with soft financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, strong revenue growth (+92.8%) is partially offset by negative earnings growth (-281.7%), weak cash generation (FCF margin -133.9%), weak profitability (net margin -496.1%).

Financial Health Rating

★★★★★
MDBH's financial health is soft, with the relatively strongest area being moderate liquidity, including working-capital and asset support (WC/assets 24.4%). Operating efficiency is weak (1 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is MDBH's strongest growth driver at +92.8% FY2025 versus FY2024 (strong, 5 stars). By comparison, free-cash-flow growth (+32.5%, solid) is also solid, while earnings growth (-281.7%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 3.2% and approximately 88.2% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 11.86% supports management-shareholder alignment.

Top 5 Institutional Investors

Pasadena Private Wealth, LLC 0.82%
UBS Group AG 0.52%
Beacon Pointe Advisors, LLC 0.29%
Susquehanna International Group, LLP 0.12%
Morgan Stanley - Brokerage Accounts 0.00%

Unit Economics (Per $1K Revenue)

★★★★★
MDBH generates approximately $-2,496 of gross profit, $-4,085 of operating income, and $-1,339 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.05%

Quantitative Style Profile

★★★★★
MDBH has a liquid profile. Weak momentum is the primary drawback, while elevated volatility.

Style Classification

Quality Focused

Value-OrientedHigh VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Broker Dealer & Intellectual Property ServiceUnderwriting fees, private placement commissions, and subscription/research fees from PatentVest analytics.The company generates revenue primarily by helping small technology startups raise capital and by selling specialized patent intelligence reports.
Technology DevelopmentIncubation and research initiatives focused on proprietary life sciences platforms.Long-term value creation efforts centered on developing early-stage scientific assets.

Valuation

Trailing PE -
Forward PE -
Enterprise Value 6.67M
Price to Sales(TTM) 2.87
Enterprise Value 6.67M
Price to Sales(TTM) 2.87
Enterprise Value to Revenue 1.11
Enterprise Value to EBITDA 1.12
Shares Outstanding 5.44M
Shares Floating 4.80M
Shares Outstanding 5.44M
Shares Floating 4.80M
Percent Insiders 11.86
Percent Institutions 3.21

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.